Global Computer Vision in Healthcare Market Size Report Segmented by Component (Hardware, Software, Services), Type (PC & Smart Camera-based), Application (Medical Imaging, Surgeries), End-user (Hospitals, Clinics, Diagnostic Centers) Forecast to 2031

The global computer vision in healthcare market is expected to grow at a CAGR of ~25% during the forecast period. The rising adoption of AI in diagnostics and early disease detection, surge in volume of medical imaging data, integration of computer vision in robotics and minimal invasive surgeries, increasing investments in healthcare IT infrastructure and growing aging population requiring frequent diagnostics are some of the key factors driving the market growth. To learn more about the research report, download a sample report.

Computer vision is a branch of artificial intelligence (AI) that allows machines to understand and evaluate visual information from the outside world, including live feeds, movies, and photographs, in the same way as humans do. By utilising deep learning algorithms, pattern recognition, and image processing, computer vision enables systems to identify objects, classify images, and even make informed decisions based on visual input. Computer vision in healthcare refers to the application of AI-powered visual recognition technologies in medical settings, where machines are trained to interpret and analyze medical images and visual data for clinical decision-making. These technologies play an important role in improving diagnostic accuracy, optimizing treatment processes, and enhancing patient monitoring. Some of the key applications of computer vision in healthcare include medical imaging analysis, surgical assistance, patient monitoring, workflow automation, and pathology & dermatology, among others. Overall, computer vision technologies help deliver faster, more precise, and cost-effective healthcare services, making them a vital component of the digital transformation in medicine.

To learn more about this report, download the PDF brochure

Transformative role of computer vision in healthcare diagnostics

The growing integration of artificial intelligence (AI) in diagnostic practices is one of the key factors fueling the growth of computer vision in the healthcare market. Diagnostic imaging techniques, such as X-rays, CT scans, and MRIs, produce a large volume of complex visual data that needs accurate interpretation. However, these traditional methods of interpretation are often time-consuming and prone to human error. Computer vision and AI improve the accuracy of diagnostic techniques by detecting anomalies that may be missed by clinicians, thereby supporting faster and more precise diagnosis. This technology enhances operational efficiency by reducing the administrative burden on radiologists and accelerating the diagnostic process. It also facilitates early disease detection, especially in conditions like cancer, neurological disorders, and cardiovascular diseases, where timely intervention is critical.

Further enhancing the effectiveness and dependability of computer vision in diagnostics are- advancements in deep learning models and the growing availability of annotated imaging datasets. AI-driven diagnostic technologies are also increasingly becoming foundational tools in hospitals, research labs, and surgical suites as clinicians seek more precise and time-efficient clinical workflows. Moreover, as healthcare ecosystems become more data-driven, computer vision is increasingly recognized as a key enabler of predictive, preventive, and personalized care.

To learn more about this report, download the PDF brochure

Optimizing early-stage drug discovery with computer vision technologies

In the evolving healthcare industry, one of the key trends is the application of computer vision in drug discovery and development. In the past, early-stage drug screening involved manually analyzing thousands of cellular images, which was not only tedious but was more prone to mistakes. However, computer vision has enabled pharmaceutical companies to automate the analysis of large experimental imaging data, thereby expediting the identification of useful drug candidates based on structural alterations or detailed cellular responses with better speed and efficiency.

By incorporating advanced computer vision algorithms, tasks such as in-vitro disease monitoring, fluorescence change quantification, and cell behaviour patterns can all be done with minimal human intervention. This automation enables researchers to focus resources on the most promising compounds while swiftly eliminating inefficient candidates.

Additionally, computer vision increases the precision of predicting drug efficacy and toxicity during preclinical testing when combined with AI models and bioinformatics platforms. This integration speeds up the entire research process and improves decision-making during the initial phases of research. The widespread adoption of computer vision in drug discovery pipelines is driven by the imperative tostreamline research and reduce the substantial time and costsassociated with traditional methods. Together, these advances position computer vision as a fundamental trend set to reshape the future of the broader healthcare AI landscape

Technological advancements driving the market growth

Recent innovations in digital health and clinical research reflect a shift toward AI-enabled platforms that streamline patient interaction and enhance operational efficiency. Companies are developing tools that enhance patient engagement, accelerate trial processes, and support more precise, data-driven decision-making across healthcare workflows. For instance,

• In April 2025, Tempus AI, Inc. introduced Tempus Loop, an AI-powered platform that integrates real-world patient data, high-throughput CRISPR functional screens, and human-derived biological models to accelerate oncology target discovery and validation, bridging the gap between preclinical research and patient therapy
• In September 2024, AiCure introduced H.Code, a next-generation patient engagement platform, at the 14th Annual DPHARM Conference. H.Code leverages AI-driven computer vision, app-based communication tools, and predictive analytics to help clinical teams remotely monitor and anticipate participant behavior, improve protocol adherence, and develop digital behavioral assessments that link patient actions with disease progression and treatment outcomes
• In March 2024, NVIDIA Corporation launched a catalogue of over two dozen GPU-accelerated, cloud-native microservices designed for healthcare, under its NIM (NVIDIA Inference Microservices) architecture. These services include AI models and workflows optimized for biology, chemistry, medical imaging, natural language, and speech recognition, among other features, which help accelerate drug discovery, MedTech, genomics, and digital health applications

Competitive Landscape Analysis

The global computer vision in healthcare market is marked by the presence of established and emerging market players such as NVIDIA Corporation; Intel Corporation; Microsoft Corporation; Advanced Micro Devices, Inc.; Google LLC; AiCure LLC; iCAD, Inc.; Thermo Fisher Scientific Inc.; Artisight, Inc.; care.ai, Inc.; Basler AG; and Tempus AI, Inc. among others.

Report Scope

Growth Rate

Report Metric	Details
Base Year Considered	2025
Historical Data	2024 - 2025
Forecast Period	2026 2031
~25%
Market Drivers	Rising adoption of AI in diagnostics & early disease detection Surge in volume of medical imaging data Increasing integration with robotic & minimal invasive surgeries Rising investment in healthcare IT infrastructure Growing geriatric population requiring frequent diagnostics
Attractive Opportunities	Shift toward cloud-based vision platforms Integration with wearables and vision-enabled remote patient monitoring Expansion of AI-enabled vision tools in emerging economies Growing demand for workflow automation and optimization
Segment Scope	Component, Type, Application, and End-user
Regional Scope	North America (US & Canada) Europe (UK, Germany, France, Italy, Spain, Rest of Europe) Asia Pacific (China, India, Japan, Rest of Asia Pacific) Latin America Middle East & Africa
Key Companies Mapped	NVIDIA Corporation; Intel Corporation; Microsoft Corporation; Advanced Micro Devices, Inc.; Google LLC; AiCure LLC; iCAD, Inc.; Thermo Fisher Scientific Inc.; Artisight, Inc.; care.ai, Inc.; Basler AG; and Tempus AI, Inc., among others.
Report Highlights	Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis

Global Computer Vision in Healthcare Market Segmentation

This report by Medi-Tech Insights provides thesize of the global computer vision in healthcare market at theregional- and country-level from 2024 to 2031. The report further segments the market based on component, type, application, and end-user.

Market Size & Forecast (2024-2031), By Component, USD Million

• Hardware
• Software
• Services

Market Size & Forecast (2024-2031), By Type, USD Million

• PC-based Computer Vision Systems
• Smart Camera-based Computer Vision Systems

Market Size & Forecast (2024-2031), By Application, USD Million

• Medical Imaging & Diagnostics
• Surgical Assistance
• Patient Monitoring & Managemen Discovery
• Other

Market Size & Forecast (2024-2031), By End-user, USD Million

• Hospitals & Clinics
• Diagnostic Centers
• Research Institutions
• Biopharma Companies
• Other

Market Size & Forecast (2024-2031), By Region, USD Million

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Rest of Asia Pacific
• Latin America
• Middle East & Africa

Key Strategic Questions Addressed

• What is the market size & forecast of the computer vision in healthcare market?
• What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the computer vision in healthcare market?
• What are the key trends defining the market?
• What are the major factors impacting the market?
• What are the opportunities prevailing in the market?
• Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
• Who are the major players operating in the market?
• What are the key strategies adopted by players?